1TKX image
Deposition Date 2004-06-09
Release Date 2004-12-07
Last Version Date 2024-11-06
Entry Detail
PDB ID:
1TKX
Keywords:
TRANSFERASE
Title:
CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
Biological Source:
Source Organism:
Human immunodeficiency virus 1 (Taxon ID: 11676)
Host Organism:
Escherichia coli
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.85 Å
R-Value Free:
0.28
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
1TKX validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Pol polyprotein, Reverse transcriptase, Chain A
Gene (Uniprot):gag-pol
Chain IDs:A
Chain Length:560
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Pol polyprotein, Reverse transcriptase, Chain B
Gene (Uniprot):gag-pol
Chain IDs:B
Chain Length:440
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
UniProt ID:P04585 Pfam ID:PF00078, PF06817, PF06815, PF00075
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSD A CYS 3-SULFINOALANINE
Ligand Molecules
GWB
Primary Citation
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.
Freeman, G.A, Andrews Iii, C.W, Hopkins, A.L, Lowell, G.S, Schaller, L.T, Cowan, J.R, Gonzales, S.S, Koszalka, G.W, Hazen, R.J, Boone, L.R, Ferris, R.G, Creech, K.L, Roberts, G.B, Short, S.A, Weaver, K, Reynolds, D.J, Milton, J, Ren, J, Stuart, D.I, Stammers, D.K, Chan, J.H, Ren, J, Nichols, C.E, Chamberlain, P.P, Weaver, K.L, Short, S.A, Stammers, D.K, Chamberlain, P.P, Ren, J, Nichols, C.E, Douglas, L, Lennerstrand, J, Larder, B.A, Stuart, D.I, Stammers, D.K, Ren, J, Nichols, C, Bird, L, Chamberlain, P, Weaver, K.L, Short, S.A, Stuart, D.I, Stammers, D.K, Chan, J.H, Hong, J.S, Hunter III, R.N, Orr, G.F, Cowan, J.R, Sherman, D.B, Sparks, S.M, Reitter, B.E, Hazen, C.W, Andrews III, R.J, St Clair, M, Boone, L.R, Ferris, R.G, Roberts, K.L, Cree, G.B, Short, S.A, Weaver, K, Ott, R.J, Ren, J, Hopkins, A, Stuart, D.I, Stammers, D.K, Ren, J, Milton, J, Weaver, K.L, Short, S.A, Stuart, D.I, Stammers, D.K, Ren, J, Nichols, C, Bird, L.E, Fujiwara, T, Suginoto, H, Stuart, D.I, Stammers, D.K, Ren, J, Diprose, J, Warren, J, Esnouf, R.M, Bird, L.E, Ikemizu, S, Slater, M, Milton, J, Balzarini, J, Stuart, D.I, Stammers, D.K, Ren, J, Esnouf, R.M, Hopkins, A.L, Stuart, D.I, Stammers, D.K, Hopkins, A.L, Ren, J, Tanaka, H, Baba, M, Okamato, M, Stuart, D.I, Stammers, D.K, Ren, J, Esnouf, R.M, Hopkins, A.L, Warren, J, Balzarini, J, Stuart, D.I, Stammers, D.K, Ren, J, Esnouf, R.M, Hopkins, A.L, Jones, E.Y, Kirby, I, Keeling, J, Ross, C.K, Larder, B.A, Stuart, D.I, Stammers, D.K, Esnouf, R.M, Ren, J, Garman, E, Somers, D.O, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, Esnouf, R.M, Ren, J, Hopkins, A.L, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, L Hopkins, A, Ren, J, Esnouf, R.M, Willcox, B.E, Jones, E.Y, Ross, C.K, Miyasaka, T, Walker, R.T, Tanaka, H, Stammers, D.K, Stuart, D.I, Ren, J, Esnouf, R.M, Hopkins, A.L, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, Ren, J, Esnouf, R.M, Garman, E, Somers, D.O, Ross, C.K, Kirby, I, Keeling, J, Darby, G, Jones, E.Y, Stuart, D.I, Stammers, D.K, Esnouf, R.M, Ren, J, Ross, C.K, Jones, E.Y, Stammers, D.K, Stuart, D.I, Stammers, D.K, Somers, D.O, Ross, C.K, Kirby, I, Ray, P.H, Wilson, J.E, Norman, M, Ren, J, Esnouf, R.M, Garman, E, Jones, E.Y, Stuart, D.I.Show
J.Med.Chem. 47 5923 5936 (2004)
PMID: 15537347 DOI: 10.1021/jm040072r

Abstact

HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs) are part of the combination therapy currently used to treat HIV infection. The features of a new NNRTI drug for HIV treatment must include selective potent activity against both wild-type virus as well as against mutant virus that have been selected by use of current antiretroviral treatment regimens. Based on analogy with known HIV-1 NNRTI inhibitors and modeling studies utilizing the X-ray crystal structure of inhibitors bound in the HIV-1 RT, a series of substituted 2-quinolones was synthesized and evaluated as HIV-1 inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
1TKX